Overview

A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Status:
Recruiting

Trial end date:
2023-11-01

Target enrollment:

Participant gender:

Summary

This is a study to confirm the efficacy of levetiracetam as adjunctive treatment or as monotherapy in pediatric epilepsy subjects aged 1 month to less than 4 years of age with partial seizures.

Phase:

Phase 3

Details

Lead Sponsor:

UCB Japan Co. Ltd.

Treatments:

Etiracetam
Levetiracetam
Piracetam